节点文献

奥美拉唑碳酸氢钠胶囊治疗十二指肠溃疡119例

Effect of Omeprazole/Sodium Bicarbonate Capsule on Duodenal Ulcer in 119 Cases of Patient

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张馨梅张振玉孙士其胡乃中吕农华王少峰杨玉秀倪润洲丁岩冰

【Author】 ZHANG Xinmei;ZHANG Zhenyu;SUN Shiqi;HU Naizhong;LYU Nonghua;WANG Shaofeng;YANG Yuxiu;NI Runzhou;DING Yanbing;Department of Gastroenterology, the First Hospital of Nanjing City, Nanjing Medical University;Department of Gastroenterology,the First Affiliated Hospital of Anhui Medical University;Department of Gastroenterology,the First Affiliated Hospital of Nanchang University;Department of Gastroenterology,the Second Affiliated Hospital of Suzhou University;Department of Gastroenterology,People’s Hospital,Henan Province;Department of Gastroenterology,the Affiliated Hospital of Nantong University;Department of Gastroenterology,the First People’s Hospital,Yangzhou City, Jiangsu Province;

【通讯作者】 张振玉;

【机构】 南京医科大学附属南京医院南京市第一医院消化科安徽医科大学第一附属医院消化科南昌大学附属第一医院消化科苏州大学附属第二医院消化科河南省人民医院消化科南通大学附属医院消化科江苏省扬州市第一人民医院消化科

【摘要】 目的观察奥美拉唑碳酸氢钠胶囊治疗活动性十二指肠溃疡的临床疗效和安全性。方法活动性十二指肠溃疡患者238例,随机分为治疗组与对照组各119例。治疗组给予奥美拉唑碳酸氢钠胶囊治疗,对照组给予奥美拉唑镁肠溶片治疗,疗程均为4周。比较两组治疗前后胃镜下溃疡分期和临床症状指标变化,及药物不良反应发生情况。结果治疗后,治疗组与对照组相比溃疡愈合显效率(86.73%比85.59%)与有效率(96.46%比97.30%)差异均无统计学意义(P>0.05)。两组临床症状均显著缓解,用药4周后治疗组嗳气评分下降值显著大于对照组[(1.36±0.76)比(1.09±0.60),P<0.05];用药2周及4周后,治疗组临床症状总分下降值均显著大于对照组[2周后(4.54±2.58)比(3.78±2.12),P<0.05];4周后[(5.33±2.77)比(4.53±1.93),P<0.05]。用药4周后,治疗组的疼痛消失率高于对照组(96.26%比95.19%),但差异无统计学意义(P>0.05)。两组不良反应差异无统计学意义。结论奥美拉唑碳酸氢钠胶囊治疗十二指肠溃疡疗效显著,效果确切,安全性好。

【Abstract】 Objective To investigate the effect and safety of omeprazole/sodium bicarbonate capsule in treatment of active duodenal ulcer. Methods Totally, 238 patients with active duodenal ulcers were randomly divided into the treatment group and the control group with 119 patients in each group.The treatment group was treated with omeprazole/sodium bicarbonate capsule, and the control group treated with omeprazole magnesium enteric tablet.The treatment course was 4 weeks.The stage classification of ulcer under endoscopy and clinical symptoms were compared between the groups before and after the treatment. Results After treatment, the stage of ulcers under endoscopy was significantly improved in both groups, but the proportion of patients in stage S1 or S2, and patients with ulcer area reduction more than 50% had no statistical differences between the treatment group and the control group(86.73% vs.85.59%,and 96.46% vs.97.30%, respectively, P>0.05).The clinical symptoms were significantly improved in both groups.After 4 weeks of treatment, the decline of belching score was significantly greater in the treatment group than in the control group(1.36±0.76 vs.1.09±0.60,P<0.05).The decline of total symptom score was significantly greater in the treatment group than in the control group after 2 and 4 weeks(4.54±2.58 vs.3.78±2.12, and 5.33±2.77 vs. 4.53±1.93, respectively, P<0.05).After 4 weeks of treatment, the rate of pain disappearance in the treatment group was higher than that in the control group(96.26% vs.95.19%), but without statistical difference(P>0.05).There were no statistical differences in adverse drug reactions between the two groups. Conclusion Omeprazole/sodium bicarbonate capsule has definite therapeutic effect and good safety in treating active duodenal ulcer.

  • 【文献出处】 医药导报 ,Herald of Medicine , 编辑部邮箱 ,2019年04期
  • 【分类号】R573.1
  • 【被引频次】5
  • 【下载频次】198
节点文献中: 

本文链接的文献网络图示:

本文的引文网络